The Journal of Allergy and Clinical Immunology
Volume 116, Issue 4 , Pages 768-772 , October 2005

Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen

  • Beth E. Davis, BSc
    • ,
  • David C. Todd, MD, FRCP(C)
    • ,
  • Donald W. Cockcroft, MD, FRCP(C)

      Affiliations

    • Corresponding Author InformationReprint requests: Donald W. Cockcroft, MD, FRCP(C), Division of Respiratory Medicine, University of Saskatchewan, Ellis Hall, Rm 551, 5th Floor, Saskatoon, SK S7N 0W8 Canada.

Received 25 April 2005 ,Revised 6 June 2005 ,Accepted 13 June 2005.

  • Image Result

    Allergen PC20 (geometric mean) for each treatment. Extract units are generically identified as units per milliliter. Error bars represent SEM.

    Allergen PC20 (geometric mean) for each treatment. Extract units are generically identified as units per milliliter. Error bars represent SEM.

 We are grateful to Merck Frosst Canada Ltd for supplying montelukast tablets and for partial funding and to Schering Canada Inc for supplying desloratadine tablets.Disclosure of potential conflict of interest: D. Cockcroft receives grants and research support from Merck Frosst Canada Inc, is on the Advisory Board for Merck Frosst Canada Inc, and receives funds from Schering Canada Inc. B. Davis and D. Todd—none disclosed.

PII: S0091-6749(05)01514-9

doi: 10.1016/j.jaci.2005.06.014

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 4 , Pages 768-772 , October 2005

Article Tools

* Image Usage & Resolution